Using Vimentin as an EMT marker, Su et al. found that IL-32β can induce Slug and Vimentin expression in breast cancer cells, thereby proving that IL-32 causes the onset of EMT in breast cancer cells [14]. This evidence concerns the gene VIM and breast carcinoma.